Panelists discuss how testing for specific changes in cancer cells, like ESR1 mutations, can help guide treatment choices for patients with hormone receptor-positive metastatic breast cancer.

Here is a recap of every FDA approval announced by the regulatory agency in the month of April, spanning various cancer types ...

Mehta-Shah is an associate professor in the Division of Oncology at Washington University School of Medicine in Saint Louis, Missouri.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.

Dr. Neha Mehta-Shah discusses ways patients with rare blood cancers, such as lymphoma, can better understand their specific ...

A new endoscopic tunneling method, STER, allowed a patient to have a GIST removed without surgery, allowing quicker recovery ...

Teddy bears offer emotional comfort and connection for adults with cancer, easing anxiety and fostering trust during ...

A patient with heavily pretreated relapsed/refractory diffuse large B-cell lymphoma achieved complete remission following ...

A phase 1 trial has initiated and is investigating treatment with ziftomenib plus Gleevec in advanced GIST following ...

LUT014, a BRAF inhibitor gel, improved acne-like rashes in patients with colorectal cancer undergoing anti-EGFR therapy, ...

The FDA has completed its 30-day review of an application for Hepzato in combination with standard of care in liver-dominant ...

Ghoreifi works with the House Staff and is a part of Duke Urologic Oncology Fellowship, Duke Urology, at Duke School of Medicine, located in Durham, North Caroline.